BIOMAT Database Logo BIOMAT Database Logo

Group B streptococcus: the pregnant woman and her neonate. 1987

S E Gaffney, and L Salinger

Within the past 10 years, group B streptococcal disease has emerged as a major causative agent in neonatal morbidity and mortality. A brief history of this pathogen and its epidemiologic factors regarding maternal colonization and carriage is presented. Group B streptococcal disease in the neonate and concurrent treatment and prevention modalities also are presented. A case study is included. Suggestions for nursing assessment, intervention, and future considerations are offered.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

S E Gaffney, and L Salinger
Pemphigus vulgaris in a pregnant woman and her neonate.
June 2012, BMJ case reports,
S E Gaffney, and L Salinger
[Management of a pregnant woman with Streptococcus group B].
May 1988, Revue francaise de gynecologie et d'obstetrique,
S E Gaffney, and L Salinger
The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.
May 1980, American journal of obstetrics and gynecology,
S E Gaffney, and L Salinger
[Genital carriage of Streptococcus group B in the pregnant woman in Abidjan (Ivory Coast)].
January 1991, Bulletin de la Societe de pathologie exotique (1990),
S E Gaffney, and L Salinger
[16-week pregnant woman with positive urine culture for group B Streptococcus (GBS) or Streptococcus agalactiae].
May 2005, Atencion primaria,
S E Gaffney, and L Salinger
[Colonization of the pregnant woman and the newborn by group B streptococcus: therapeutic and preventive implications].
August 1978, Schweizerische medizinische Wochenschrift,
S E Gaffney, and L Salinger
[Neonatal infection and universal screening for Streptococcus agalactiae (group B β-hemolytic Streptococcus) in the pregnant woman: Technical recommendation].
June 2017, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
S E Gaffney, and L Salinger
The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies.
May 1980, American journal of obstetrics and gynecology,
S E Gaffney, and L Salinger
[Streptococcus group B screening in pregnant women].
February 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S E Gaffney, and L Salinger
[Group B Streptococcus carriers among pregnant women].
January 2003, Revista Argentina de microbiologia,
Copied contents to your clipboard!